Different groups have also identified osteopontin, Insulin-like-Growth Factor-1 (IGF-1) or the pro-inflammatory peptide LL-37 as possible secreted factors by cancer cells, which could increase CCL5 levels in MSCs [43–45]. The gene discussed is SPP1; the disease is cancer.